Abstract

N,N-diethyl-m-toluamide (DEET) has been registered for commercial use as an insect repellent for over five decades, and is used widely across the world. Concerns over the safety of DEET first emerged during the 1980s after reports of encephalopathy following DEET exposure, particularly in children. However, the role of DEET in either the illness or deaths was and remains purely speculative. In response to these cases a number of reviews and investigations of DEET safety were carried out. Here we examine the methods used and information available to determine the safety of DEET in humans. Animal testing, observational studies and intervention trials have found no evidence of severe adverse events associated with recommended DEET use. Minor adverse effects noted in animal trials were associated with very large doses and were not replicated between different test species. The safety surveillance from extensive humans use reveals no association with severe adverse events. This review compares the toxicity assessment using three different models to define the risk assessment and safety threshold for DEET use in humans and discusses the clinical consequences of the thresholds derived from the models.The theoretical risks associated with wearing an insect repellent should be weighed against the reduction or prevention of the risk of fatal or debilitating diseases including malaria, dengue, yellow fever and filariasis. With over 48 million European residents travelling to regions where vector borne diseases are a threat in 2009, restricting the concentration of DEET containing repellents to 15% or less, as modelled in the 2010 EU directive, is likely to result in extensive sub-therapeutic activity where repellents are infrequently applied. Future European travellers, as a consequence of inadequate personal protection, could potentially be at increased risk of vector borne diseases. Risk assessments of repellents should take these factors into account when setting safe limits.

Highlights

  • N,N-diethyl-m-toluamide (DEET) is amongst the most effective and widely used of insect repellents [1]

  • Risk assessments of chemical exposures rely on exposure and toxicity assessments which both involve a margin of error

  • Risk assessments use a conservative estimate of exposure to describe the lowest safe estimates of toxicity

Read more

Summary

Introduction

N,N-diethyl-m-toluamide (DEET) is amongst the most effective and widely used of insect repellents [1]. The 1% of the NOEL, as established from animal testing, is recognised as the safe exposure limit This means a 40% DEET product is qualified as unsafe for human use but is based on rat experimental data, where animals at higher dose exposures developed non-specific weight loss and male renal abnormalities. The 2010 EU directive, using the same data source as the USEPA recommends an acceptable exposure level (AEL) for repeated use of 8.2 mg DEET per kg body weight per day [29] This dose is equivalent to a single application of 3.3 g of a 15% DEET formulation to an adult weighing 60 kg. In field testing of 20-35% DEET formulations, investigators have used up to 6 ml to protect exposed limbs, usually forearms, lower legs and feet [38], but sometimes only the lower legs [39,40]

Conclusions
Nentwig G
24. Miller JD
29. European Commission
Findings
41. World Tourism Organisation UNWTO: Yearbook of Tourism Statistics
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call